Literature DB >> 6786637

Oral contraceptive steroid plasma concentrations in smokers and non-smokers.

F E Crawford, D J Back, M L Orme, A M Breckenridge.   

Abstract

A study was performed to find out whether the overall rate of metabolism of oral contraceptives is affected by smoking and whether this explains the increased incidence of cardiovascular disease in users of oral contraceptives who smoke. Plasma ethinyloestradiol and norgestrel concentrations in 311 women using oral contraceptives were similar in smokers and non-smokers. The overall rate of metabolism of contraceptive steroids does not therefore seem to be affected by cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786637      PMCID: PMC1506412          DOI: 10.1136/bmj.282.6279.1829

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  3 in total

1.  Antiethinyloestradiol antibody activities in oral contraceptive users.

Authors:  J L Beaumont; N Lemort; L Lorenzelli-Edouard; B Delplanque; V Beaumont
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

2.  Metabolism of 17 alpha-ethinylestradiol by human liver microsomes in vitro: aromatic hydroxylation and irreversible protein binding of metabolites.

Authors:  H M Bolt; H Kappus; R Käsbohrer
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

Review 3.  Influence of cigarette smoking on drug metabolism in man.

Authors:  W J Jusko
Journal:  Drug Metab Rev       Date:  1979       Impact factor: 4.518

  3 in total
  8 in total

Review 1.  Progress in clinical pharmacology over the last 20 years.

Authors:  Michel Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  2003-05       Impact factor: 4.335

Review 2.  Pharmacokinetic drug interactions with oral contraceptives.

Authors:  D J Back; M L Orme
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

3.  Effects of tobacco smoking and oral contraceptive use on theophylline disposition.

Authors:  M J Gardner; K M Tornatore; W J Jusko; R Kanarkowski
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

Review 4.  Clinical pharmacokinetics of oral contraceptive steroids.

Authors:  M L Orme; D J Back; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

Review 5.  Drug interactions with tobacco smoking. An update.

Authors:  S Zevin; N L Benowitz
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of contraceptive steroids. An update.

Authors:  G M Shenfield; J M Griffin
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 7.  Oral contraceptives. Are drug interactions of clinical significance?

Authors:  G M Shenfield
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

8.  Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 alpha-ethinyloestradiol. Relative activities of rat and human liver enzymes.

Authors:  S E Ball; L M Forrester; C R Wolf; D J Back
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.